Pathogenesis and management of renovascular hypertension and ischemic nephropathy

Minerva Urologica e Nefrologica

Volumn 64, Issue 1, 2012, Pages 63-72

  Yerram, P ^a   Karuparthi, P R ^b   Chaudhary, K ^a,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hypertension, renovascular; Kidney disease; Renal artery obstruction

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CAPTOPRIL; CARBON DIOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CREATININE CLEARANCE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE CONTROL; DISEASE COURSE; DIURETIC THERAPY; ECHOGRAPHY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; ISCHEMIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY PERFUSION; KIDNEY SIZE; LIFESTYLE MODIFICATION; LUNG EDEMA; MAGNETIC RESONANCE ANGIOGRAPHY; MICROVASCULARIZATION; NATRIURESIS; NEPHROTIC SYNDROME; NON INVASIVE PROCEDURE; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOGRAPHY; RENOVASCULAR HYPERTENSION; RESTENOSIS; REVASCULARIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STENT; ULTRAFILTRATION; UREMIA;

HUMANS; HYPERTENSION, RENOVASCULAR; ISCHEMIA; KIDNEY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL ARTERY OBSTRUCTION; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; STENTS; TREATMENT OUTCOME; UNITED STATES;

EID: 84860308721     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. American Journal of Hypertension 2010;23:1159-69.
2. Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 1997;15:1365-77. (Pubitemid 28039562)
3. Lorenz EC, Vrtiska TJ, Lieske JC, Dillon JJ, Stegall MD, Li X et al. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clinical journal of the American Society of Nephrology. CJASN 2010;5:431-8.
4. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344:431-42. (Pubitemid 32128677)
5. Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol 2004;15:1974-82. (Pubitemid 39031336)
6. Hansen KJ, Edwards MS, Crav en TE, Cherr GS, Jackson SA, Appel RG et al. Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg 2002;36:443-51.
7. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens 2009;27:1333-40.
8. Sawicki PT, Kaiser S, Heinemann L, Frenzel H, Berger M. Prevalence of renal artery stenosis in diabetes mellitus - an autopsy study. J Intern Med 1991;229:489-92.
9. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;24:622-9. (Pubitemid 24318918)
10. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993;341:415-8. (Pubitemid 23048156)
11. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment - a case for treatment. Clin Nephrol 1989;31:119-22. (Pubitemid 19080446)
12. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: I. the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934;59:347-79.
13. Braun-Menendez E, Fasciolo JC, Leloir LF, Munoz JM. The substance causing renal hypertension. J Physiol 1940;98: 283-98.
14. Page IH. On the Nature of the pressor action of renin. J Exp Med 1939;70:521-42.
15. Skeggs LT, Dorer FE, Kahn JR, Lentz KE, Levine M. The biochemistry of the renin-angiotensin system and its role in hypertension. Am J Med 1976;60:737-48.
16. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 1973;55:261-74.
17. Laragh JH, Sealey J, Branner HR. The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension. Am J Med 1972;53:649-63.
18. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-56. (Pubitemid 28516069)
19. Salifu MO, Haria DM, Badero O, Aytug S, McFarlane SI. Challenges in the diagnosis and management of renal artery stenosis. Current Hypertension Reports 2005;7:219-27. (Pubitemid 40894928)
20. Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med 2001;52:421-42. (Pubitemid 32195333)
21. Nawar T, Lefebvre R, Rojo-Ortega JM, Cartier P, Genest J. Reversal of ischemic tubular atrophy. Ann Intern Med 1970;72:529-32.
22. Novick AC. Options for therapy of ischemic nephropathy: role of angioplasty and surgery. Semin Nephrol 1996;16:53-60.
23. Pohl M. Renovascular hypertension and ischemic nephropathy. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.
24. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984;11:383-92. (Pubitemid 14060862)
25. Wolf K, Kurtz A. Renal artery stenosis rapidly enhances atrial natriuretic peptide gene expression. Hypertension 1995;26:1011-7.
26. Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med 1983;308:373-6. (Pubitemid 13187219)
27. Gephardt GN, Tubbs RR, Novick AC, McMahon JT, Pohl MA. Renal artery stenosis, nephrotic-range proteinuria, and focal and segmental glomerulosclerosis. Cleve Clin Q 1984;51:371-6. (Pubitemid 14038039)
28. Zimbler MS, Pickering TG, Sos TA, Laragh JH. Proteinuria in renovascular hypertension and the effects of renal angioplasty. Am J Cardiol 1987;59:406-8. (Pubitemid 17032892)
29. Napoli V, Pinto S, Bargellini I, Vignali C, Cioni R, Petruzzi P et al. Duplex ultrasonographic study of the renal arteries before and after renal artery stenting. Eur Radiol 2002;12:796-803. (Pubitemid 36940136)
30. Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995;122:833-8.
31. Ohta Y, Fujii K, Arima H, Matsumura K, Tsuchihashi T, Tokumoto M et al. Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography. J Hypertens 2005;23:1905-11. (Pubitemid 41830431)
32. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J et al. Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting. Am J Cardiol 2001;88:1064-6. (Pubitemid 33042630)
33. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-7. (Pubitemid 32128673)
34. Nally JV Jr, Clarke HS Jr, Grecos GP, Saunders M, Gross ML, Potvin WJ et al. Effect of captopril on 99mTc-diethylenetriaminepentaacetic acid renograms in two-kidney, one clip hypertension. Hypertension 1986;8:685-93. (Pubitemid 16044341)
35. Bongers V, Bakker J, Beutler JJ, Beek FJ, De Klerk JM. Assessment of renal artery stenosis: comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. Clin Radiol 2000;55:346-53.
36. Pedersen EB. New tools in diagnosing renal artery stenosis. Kidney Int 2000;57:2657-77. (Pubitemid 30340771)
37. Lin CC, Shiau YC, Li TC, Kao A, Lee CC. Usefulness of captopril renography to predict the benefits of renal artery revascularization or captopril treatment in hypertensive patients with diabetic nephropathy. J Diabetes Complications 2002;16:344-6.
38. Eklof H, Ahlstrom H, Magnusson A, Andersson LG, Andren B, Hagg A et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol 2006;47:764-74. (Pubitemid 44521233)
39. Rountas C, Vlychou M, Vassiou K, Liakopoulos V, Kapsalaki E, Koukoulis G et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail 2007;29:295-302. (Pubitemid 46752349)
40. Glockner JF, Vrtiska TJ. Renal MR and CT angiography: current concepts. Abdom Imaging 2007;32:407-20. (Pubitemid 47077089)
41. Tan KT, van Beek EJ, Brown PW, van Delden OM, Tijssen J, Ramsay LE. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 2002;57:617-24. (Pubitemid 36113582)
42. Olin JW, Kaufman JA, Bluemke DA, Bonow RO, Gerhard MD, Jaff MR et al. Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging. Circulation 2004;109:2626-33. (Pubitemid 38720567)
43. 2 digital angiography: a safer contrast agent for renal vascular imaging? Am J Kidney Dis 1994;24:685-94.
44. Wilson AJ, Boxer MM. Neurotoxicity of angiographic carbon dioxide in the cerebral vasculature. Invest Radiol 2002;37:542-51.
45. Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med 2009;361:1972-8.
46. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004;350:1862-71.
47. Birrer M, Do DD, Mahler F, Triller J, Baumgartner I. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002;23:146-52. (Pubitemid 41079478)
48. Safian RD, Madder RD. Refining the approach to renal artery revascularization. JACC Cardiovascular Interventions 2009;2:161-74.
49. Bloch MJ, Basile J. Clinical insights into the diagnosis and management of renovascular disease. An evidence-based review. Minerva Med 2004;95:357-73. (Pubitemid 39481895)
50. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Journal of the American College of Cardiology 2006;47:1239-312.
51. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342:1007-14.
52. Blum U, Krumme B, Flugel P, Gabelmann A, Lehnen T, Buitrago-Tellez C et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-65. (Pubitemid 27074356)
53. Dorros G, Jaff M, Mathiak L, Dorros, II, Lowe A, Murphy K et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-7. (Pubitemid 28387490)
54. Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000;216:78-85. (Pubitemid 30434724)
55. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009;150:840-8, W150-1.
56. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953-62.
57. Lao D, Parasher PS, Cho KC, Yeghiazarians Y. Atherosclerotic renal artery stenosis-diagnosis and treatment. Mayo Clin Proc 2011;86:649-57.
58. Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto AH et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol 2005;16:1295-300. (Pubitemid 41463986)
59. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006;152:59-66. (Pubitemid 43974724)